Afib management goes beyond rhythm.
The left atrial appendage is the leading source of stroke-causing clots in Afib patients. Backed by randomized clinical trial evidence and a Class IA guideline recommendation, LAA Exclusion is a critical step in reducing stroke risk when treating Afib during cardiac surgery.
Comprehensive Afib treatment requires excluding the LAA.
Learn more about why LAA Exclusion matters at: <a href="https://okt.to/kgWLNf" target="_blank">https://okt.to/kgWLNf</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAExclusion&highlighte…; target='_blank'>#LAAExclusion</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a>
